Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT00003256
Eligibility Criteria:
PATIENT CHARACTERISTICS:
* Performance Status: ECOG 0-2
* Life Expectancy: At least 3 months
* WBC at least 3,000/mm3
* Absolute neutrophil count at least 1,200/mm3
* Platelet count at least 100,000/mm3
* Hemoglobin at least 8 g/dL
* Bilirubin no greater than 1.5 mg/dL
* SGOT no greater than 2.5 times normal
* Creatinine no greater than 1.5 mg/dL
* Prostate-specific antigen at least 10 ng/mL (if bone only disease)
* No prior or concurrent maligancies within 5 years, except nonmelanoma skin cancer
* No serious medical illness
* No cord compression symptoms
PRIOR CONCURRENT THERAPY:
* No prior chemotherapy
* No prior suramin therapy
* Prior or concurrent use of luteinizing hormone-releasing hormone allowed (no other concurrent hormonal therapy)
* No prior anti-androgen therapy within 4 weeks of study
* At least 4 weeks since prior radiotherapy
* No prior strontium therapy
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT00003256
Study Brief:
Protocol Section:
NCT00003256